Shaolin Capital Management’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-249,143
| Closed | -$11.8K | – | 288 |
|
|
2024
Q2 | $11.8K | Sell |
249,143
-43,822
| -15% | -$2.08K | ﹤0.01% | 257 |
|
|
2024
Q1 | $11.4K | Sell |
292,965
-78,676
| -21% | -$3.07K | ﹤0.01% | 267 |
|
|
2023
Q4 | $11.2K | Sell |
371,641
-94,076
| -20% | -$2.84K | ﹤0.01% | 315 |
|
|
2023
Q3 | $33K | Buy |
+465,717
| New | +$33K | ﹤0.01% | 338 |
|
|
2023
Q2 | – | Sell |
-498,109
| Closed | -$18K | – | 305 |
|
|
2023
Q1 | $18K | Hold |
498,109
| – | – | ﹤0.01% | 565 |
|
|
2022
Q4 | $23K | Sell |
498,109
-164,590
| -25% | -$7.6K | ﹤0.01% | 560 |
|
|
2022
Q3 | $41K | Sell |
662,699
-161,300
| -20% | -$9.98K | ﹤0.01% | 595 |
|
|
2022
Q2 | $156K | Sell |
823,999
-1,000
| -0.1% | -$189 | ﹤0.01% | 547 |
|
|
2022
Q1 | $397K | Sell |
824,999
-16,796
| -2% | -$8.08K | 0.01% | 508 |
|
|
2021
Q4 | $1.51M | Buy |
841,795
+457,528
| +119% | +$819K | 0.04% | 422 |
|
|
2021
Q3 | $354K | Buy |
384,267
+79,182
| +26% | +$72.9K | 0.01% | 404 |
|
|
2021
Q2 | $281K | Buy |
305,085
+65,858
| +28% | +$60.7K | 0.01% | 435 |
|
|
2021
Q1 | $144K | Buy |
+239,227
| New | +$144K | 0.01% | 458 |
|